Claudia Stege

MSC.

20172019

Research output per year

If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Carfilzomib for relapsed and refractory multiple myeloma

Groen, K., van de Donk, N., Stege, C., Zweegman, S. & Nijhof, I. S., 2019, In : Cancer management and research. 11, p. 2663-2675 13 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study

Nielsen, L. K., Stege, C., Lissenberg-Witte, B., van der Holt, B., Mellqvist, U-H., Salomo, M., Bos, G., Levin, M-D., Visser-Wisselaar, H., Hansson, M., van der Velden, A., Deenik, W., Coenen, J., Hinge, M., Klein, S., Tanis, B., Szatkowski, D., Brouwer, R., Westerman, M., Leys, R. & 10 others, Sinnige, H., Haukås, E., van der Hem, K., Durian, M., Gimsing, P., van de Donk, N., Sonneveld, P., Waage, A., Abildgaard, N. & Zweegman, S., 12 Sep 2019, In : Haematologica.

Research output: Contribution to journalArticleAcademicpeer-review

CD38-targeting antibodies in multiple myeloma: mechanisms of action and clinical experience

Frerichs, K. A., Nagy, N. A., Lindenbergh, P. L., Bosman, P., Marin Soto, J., Broekmans, M., Groen, R. W. J., Themeli, M., Nieuwenhuis, L., Stege, C., Nijhof, I. S., Mutis, T., Zweegman, S., Lokhorst, H. M. & van de Donk, N. W. C. J., Mar 2018, In : Expert Review of Clinical Immunology. 14, 3, p. 197-206 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

FEASIBILITY AND EFFICACY OF DOSE ADJUSTED MELPHALAN - PREDNISONE - BORTEZOMIB IN PATIENTS >= 75 YEARS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; PRELIMINARY RESULTS OF THE PHASE II HOVON 123 STUDY

Zweegman, S., Levin, M. -D., Klein, S. K., de Waal, E. G., Eeltink, C. M., Ypma, P. F., Dijk, A. C., Westerman, M., Deenik, W., Tanis, B., Slee-Valentijn, M. S., Minnema, M. C., Visser-Wisselaar, H., Stege, C., van de Donk, N. W., Nasserinejad, K. & Sonneveld, P., 26 Jun 2017, In : Haematologica. 102, p. 112-113

Research output: Contribution to journalMeeting AbstractAcademic

Frailty predicts survival and toxicity in newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation; report of the HOVON-87/NMSG-18 study group

Stege, C. A. M., Van Der Holt, B., Mellqvist, U. H., Levin, M. D., Salomo, M., Abildgaard, N., Bos, G., Visser-Wisselaar, H., Hansson, M., Van Der Velden, A., Deenik, W., Gruber, A., Coenen, J. L. L. M., Plesner, T., Klein, S., Tanis, B., Szatkowski, D. L., Brouwer, R., Westerman, M., Leijs, M. B. & 11 others, Sinnige, H., Haukaas, E., Van Der Hem, K., Durian, M., Mattijssen, V., Gimsing, P., Van De Donk, N. W. C. J., Stevens-Kroef, M., Sonneveld, P., Waage, A. & Zweegman, S., 2017, Blood. Conference: 59th Annual Meeting of the American Society of Hematology, ASH. (Blood. Conference: 59th Annual Meeting of the American Society of Hematology, ASH; vol. 130).

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review